Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related ALXN
Leerink Is Back On Board The Biotech Train
Credit Suisse Bullish On Most Big Pharma Names
Related DHR
Earnings Scheduled For January 26, 2016
Goldman Just Downgraded These Three Life Science Stocks
Dover Probably Undervalued, But Where's The Spark? (Seeking Alpha)

Analysts at Citigroup initiated coverage on shares of Alexion Pharmaceuticals (NASDAQ: ALXN) with a “neutral” rating. Alexion's shares closed at $93.59 yesterday. Alexion's trailing-twelve-month operating margin is 35.20%.

BMO Capital initiated coverage on shares of Danaher (NYSE: DHR) with an “outperform” rating. Danaher's shares closed at $53.07 yesterday. Danaher's trailing-twelve-month revenue is $18.00 billion.

SunTrust initiated coverage on shares of Citigroup (NYSE: C) with a “buy” rating. Citigroup's stock closed at $37.02 yesterday. Citigroup had $798.78 billion in total cash for the recent quarter.

Analysts at Wedbush initiated coverage on shares of Oracle (NASDAQ: ORCL) with a “neutral” rating. Oracle's shares closed at $32.03 yesterday. Oracle's PEG ratio is 1.00.

Latest Ratings for ALXN

DateFirmActionFromTo
Feb 2016BarclaysMaintainsEqual-weight
Feb 2016JefferiesMaintainsHold
Jan 2016Credit SuisseInitiates Coverage onNeutral

View More Analyst Ratings for ALXN
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (ALXN + C)

View Comments and Join the Discussion!

Get Benzinga's Newsletters